SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3ckk'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1U70_A_MTXA187_2 (DIHYDROFOLATE REDUCTASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	4 / 4	SER A 109 ILE A 78 VAL A 82 THR A 208	None SAM A 301 (-3.8A) None SAM A 301 (-2.8A)	0.96A	1u70A-3ckkA: undetectable	1u70A-3ckkA: 22.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_E_SAME1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	GLY A 54 ARG A 79 ALA A 111 PHE A 131 GLU A 210	GOL A 302 ( 3.3A) SAM A 301 (-3.8A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-4.1A)	1.26A	2vdvE-3ckkA: 29.6	2vdvE-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_E_SAME1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	7 / 12	GLY A 54 GLU A 77 ILE A 78 ARG A 79 ASN A 110 ALA A 111 PHE A 131	GOL A 302 ( 3.3A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A)	0.91A	2vdvE-3ckkA: 29.6	2vdvE-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_E_SAME1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	7 / 12	GLY A 54 GLU A 77 ILE A 78 ARG A 79 ASN A 110 PHE A 131 ASP A 133	GOL A 302 ( 3.3A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-4.8A) GOL A 302 ( 3.6A)	1.12A	2vdvE-3ckkA: 29.6	2vdvE-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_E_SAME1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	6 / 12	GLY A 54 GLY A 56 ALA A 111 PHE A 131 THR A 208 GLU A 210	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-2.8A) SAM A 301 (-4.1A)	0.83A	2vdvE-3ckkA: 29.6	2vdvE-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_E_SAME1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	8 / 12	GLY A 54 GLY A 56 GLU A 77 ILE A 78 ASN A 110 ALA A 111 PHE A 131 THR A 208	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-2.8A)	0.35A	2vdvE-3ckkA: 29.6	2vdvE-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_E_SAME1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	8 / 12	GLY A 54 GLY A 56 GLU A 77 ILE A 78 ASN A 110 PHE A 131 ASP A 133 THR A 208	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-4.8A) GOL A 302 ( 3.6A) SAM A 301 (-2.8A)	0.69A	2vdvE-3ckkA: 29.6	2vdvE-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_F_SAMF1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 11	GLY A 54 ARG A 79 ALA A 111 PHE A 131 GLU A 210	GOL A 302 ( 3.3A) SAM A 301 (-3.8A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-4.1A)	1.25A	2vdvF-3ckkA: 29.6	2vdvF-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_F_SAMF1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	7 / 11	GLY A 54 GLU A 77 ILE A 78 ARG A 79 ASN A 110 ALA A 111 PHE A 131	GOL A 302 ( 3.3A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A)	0.91A	2vdvF-3ckkA: 29.6	2vdvF-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_F_SAMF1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	7 / 11	GLY A 54 GLU A 77 ILE A 78 ARG A 79 ASN A 110 PHE A 131 ASP A 133	GOL A 302 ( 3.3A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-4.8A) GOL A 302 ( 3.6A)	1.12A	2vdvF-3ckkA: 29.6	2vdvF-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_F_SAMF1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	6 / 11	GLY A 54 GLY A 56 ALA A 111 PHE A 131 THR A 208 GLU A 210	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-2.8A) SAM A 301 (-4.1A)	0.83A	2vdvF-3ckkA: 29.6	2vdvF-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_F_SAMF1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	8 / 11	GLY A 54 GLY A 56 GLU A 77 ILE A 78 ASN A 110 ALA A 111 PHE A 131 THR A 208	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-2.8A)	0.35A	2vdvF-3ckkA: 29.6	2vdvF-3ckkA: 53.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDV_F_SAMF1287_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	8 / 11	GLY A 54 GLY A 56 GLU A 77 ILE A 78 ASN A 110 PHE A 131 ASP A 133 THR A 208	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-4.8A) GOL A 302 ( 3.6A) SAM A 301 (-2.8A)	0.69A	2vdvF-3ckkA: 29.6	2vdvF-3ckkA: 53.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZZM_A_SAMA401_1 (UNCHARACTERIZED PROTEIN MJ0883)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	3 / 3	ARG A 216 ASP A 169 ASN A 217	None	0.84A	2zzmA-3ckkA: 10.3	2zzmA-3ckkA: 22.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CKK_A_SAMA301_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	9 / 12	GLY A 54 GLY A 56 GLU A 77 ILE A 78 ARG A 79 ASN A 110 ALA A 111 LEU A 60 THR A 208	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) None SAM A 301 (-2.8A)	1.34A	3ckkA-3ckkA: 39.0	3ckkA-3ckkA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CKK_A_SAMA301_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	12 / 12	GLY A 54 GLY A 56 GLU A 77 ILE A 78 ARG A 79 ASN A 110 ALA A 111 MET A 112 LEU A 130 ASP A 133 THR A 208 GLU A 210	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.8A) SAM A 301 (-3.8A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) GOL A 302 ( 3.3A) SAM A 301 (-4.8A) GOL A 302 ( 3.6A) SAM A 301 (-2.8A) SAM A 301 (-4.1A)	0.00A	3ckkA-3ckkA: 39.0	3ckkA-3ckkA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DXY_A_SAMA1_0 (TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	6 / 11	GLY A 54 GLY A 56 GLU A 77 ALA A 111 PHE A 131 ASP A 133	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-2.7A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) GOL A 302 ( 3.6A)	0.60A	3dxyA-3ckkA: 19.9	3dxyA-3ckkA: 24.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MTE_B_SAMB220_0 (16S RRNA METHYLASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	GLY A 54 GLY A 56 ALA A 111 LEU A 130 PHE A 131	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-4.8A)	0.77A	3mteB-3ckkA: 13.6	3mteB-3ckkA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P2K_A_SAMA6735_0 (16S RRNA METHYLASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	GLY A 54 GLY A 56 ALA A 111 LEU A 130 PHE A 131	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-4.8A)	0.69A	3p2kA-3ckkA: 5.0	3p2kA-3ckkA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3P2K_C_SAMC6735_0 (16S RRNA METHYLASE)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	GLY A 54 GLY A 56 ALA A 111 LEU A 130 PHE A 131	GOL A 302 ( 3.3A) SAM A 301 (-3.5A) SAM A 301 (-3.7A) SAM A 301 (-4.8A) SAM A 301 (-4.8A)	0.72A	3p2kC-3ckkA: 14.1	3p2kC-3ckkA: 23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOU_A_C04A207_1 (UNCHARACTERIZED PROTEIN)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	3 / 3	GLY A 56 GLU A 209 THR A 208	SAM A 301 (-3.5A) None SAM A 301 (-2.8A)	0.57A	4kouA-3ckkA: undetectable	4kouA-3ckkA: 19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCI_A_SAMA2409_0 (RNA-DIRECTED RNA POLYMERASE L)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	THR A 208 GLY A 54 GLY A 56 GLY A 58 ALA A 111	SAM A 301 (-2.8A) GOL A 302 ( 3.3A) SAM A 301 (-3.5A) None SAM A 301 (-3.7A)	0.95A	4uciA-3ckkA: 5.4	4uciA-3ckkA: 18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCI_B_SAMB2409_0 (RNA-DIRECTED RNA POLYMERASE L)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	THR A 208 GLY A 54 GLY A 56 GLY A 58 ALA A 111	SAM A 301 (-2.8A) GOL A 302 ( 3.3A) SAM A 301 (-3.5A) None SAM A 301 (-3.7A)	0.94A	4uciB-3ckkA: 5.4	4uciB-3ckkA: 18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UCK_A_SAMA2409_0 (RNA-DIRECTED RNA POLYMERASE L)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	THR A 208 GLY A 54 GLY A 56 GLY A 58 ALA A 111	SAM A 301 (-2.8A) GOL A 302 ( 3.3A) SAM A 301 (-3.5A) None SAM A 301 (-3.7A)	0.93A	4uckA-3ckkA: 5.4	4uckA-3ckkA: 18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5C0O_F_SAMF301_0 (TRNA (ADENINE(58)-N(1))-M ETHYLTRANSFERASE TRMI)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	5 / 12	GLY A 56 GLY A 58 GLY A 59 LEU A 60 GLU A 77	SAM A 301 (-3.5A) None None None SAM A 301 (-2.7A)	0.89A	5c0oF-3ckkA: 11.2	5c0oF-3ckkA: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_A_SAMA601_1 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	4 / 5	THR A 208 ASP A 52 GLU A 77 ASN A 110	SAM A 301 (-2.8A) SAM A 301 ( 4.9A) SAM A 301 (-2.7A) SAM A 301 (-3.5A)	1.06A	5ybbA-3ckkA: 4.9	5ybbA-3ckkA: 19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YBB_B_SAMB601_1 (TYPE I RESTRICTION-MODIFICA TION SYSTEM METHYLTRANSFERASE SUBUNIT)	3ckk	TRNA (GUANINE-N(7)-)-METH YLTRANSFERASE (Homo sapiens)	4 / 7	GLY A 56 GLY A 58 GLU A 77 ASN A 110	SAM A 301 (-3.5A) None SAM A 301 (-2.7A) SAM A 301 (-3.5A)	0.47A	5ybbB-3ckkA: 5.9	5ybbB-3ckkA: 19.34

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1U70_A_MTXA187_2","DIHYDROFOLATE REDUCTASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",4,"SER A 109;ILE A  78;VAL A  82;THR A 208","None;SAM A 301 (-3.8A);None;SAM A 301 (-2.8A)","0.96A","1u70A-3ckkA:undetectable","1u70A-3ckkA:22.05"],["2VDV_E_SAME1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"GLY A  54;ARG A  79;ALA A 111;PHE A 131;GLU A 210","GOL A 302 ( 3.3A);SAM A 301 (-3.8A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-4.1A)","1.26A","2vdvE-3ckkA:29.6","2vdvE-3ckkA:53.73"],["2VDV_E_SAME1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",7,"GLY A  54;GLU A  77;ILE A  78;ARG A  79;ASN A 110;ALA A 111;PHE A 131","GOL A 302 ( 3.3A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A)","0.91A","2vdvE-3ckkA:29.6","2vdvE-3ckkA:53.73"],["2VDV_E_SAME1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",7,"GLY A  54;GLU A  77;ILE A  78;ARG A  79;ASN A 110;PHE A 131;ASP A 133","GOL A 302 ( 3.3A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-4.8A);GOL A 302 ( 3.6A)","1.12A","2vdvE-3ckkA:29.6","2vdvE-3ckkA:53.73"],["2VDV_E_SAME1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",6,"GLY A  54;GLY A  56;ALA A 111;PHE A 131;THR A 208;GLU A 210","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-2.8A);SAM A 301 (-4.1A)","0.83A","2vdvE-3ckkA:29.6","2vdvE-3ckkA:53.73"],["2VDV_E_SAME1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",8,"GLY A  54;GLY A  56;GLU A  77;ILE A  78;ASN A 110;ALA A 111;PHE A 131;THR A 208","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-2.8A)","0.35A","2vdvE-3ckkA:29.6","2vdvE-3ckkA:53.73"],["2VDV_E_SAME1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",8,"GLY A  54;GLY A  56;GLU A  77;ILE A  78;ASN A 110;PHE A 131;ASP A 133;THR A 208","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-4.8A);GOL A 302 ( 3.6A);SAM A 301 (-2.8A)","0.69A","2vdvE-3ckkA:29.6","2vdvE-3ckkA:53.73"],["2VDV_F_SAMF1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"GLY A  54;ARG A  79;ALA A 111;PHE A 131;GLU A 210","GOL A 302 ( 3.3A);SAM A 301 (-3.8A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-4.1A)","1.25A","2vdvF-3ckkA:29.6","2vdvF-3ckkA:53.73"],["2VDV_F_SAMF1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",7,"GLY A  54;GLU A  77;ILE A  78;ARG A  79;ASN A 110;ALA A 111;PHE A 131","GOL A 302 ( 3.3A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A)","0.91A","2vdvF-3ckkA:29.6","2vdvF-3ckkA:53.73"],["2VDV_F_SAMF1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",7,"GLY A  54;GLU A  77;ILE A  78;ARG A  79;ASN A 110;PHE A 131;ASP A 133","GOL A 302 ( 3.3A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-4.8A);GOL A 302 ( 3.6A)","1.12A","2vdvF-3ckkA:29.6","2vdvF-3ckkA:53.73"],["2VDV_F_SAMF1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",6,"GLY A  54;GLY A  56;ALA A 111;PHE A 131;THR A 208;GLU A 210","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-2.8A);SAM A 301 (-4.1A)","0.83A","2vdvF-3ckkA:29.6","2vdvF-3ckkA:53.73"],["2VDV_F_SAMF1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",8,"GLY A  54;GLY A  56;GLU A  77;ILE A  78;ASN A 110;ALA A 111;PHE A 131;THR A 208","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-2.8A)","0.35A","2vdvF-3ckkA:29.6","2vdvF-3ckkA:53.73"],["2VDV_F_SAMF1287_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",8,"GLY A  54;GLY A  56;GLU A  77;ILE A  78;ASN A 110;PHE A 131;ASP A 133;THR A 208","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-4.8A);GOL A 302 ( 3.6A);SAM A 301 (-2.8A)","0.69A","2vdvF-3ckkA:29.6","2vdvF-3ckkA:53.73"],["2ZZM_A_SAMA401_1","UNCHARACTERIZED PROTEIN MJ0883","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",3,"ARG A 216;ASP A 169;ASN A 217","None","0.84A","2zzmA-3ckkA:10.3","2zzmA-3ckkA:22.32"],["3CKK_A_SAMA301_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",9,"GLY A  54;GLY A  56;GLU A  77;ILE A  78;ARG A  79;ASN A 110;ALA A 111;LEU A  60;THR A 208","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);None;SAM A 301 (-2.8A)","1.34A","3ckkA-3ckkA:39.0","3ckkA-3ckkA:100.00"],["3CKK_A_SAMA301_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",12,"GLY A  54;GLY A  56;GLU A  77;ILE A  78;ARG A  79;ASN A 110;ALA A 111;MET A 112;LEU A 130;ASP A 133;THR A 208;GLU A 210","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.8A);SAM A 301 (-3.8A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);GOL A 302 ( 3.3A);SAM A 301 (-4.8A);GOL A 302 ( 3.6A);SAM A 301 (-2.8A);SAM A 301 (-4.1A)","0.00A","3ckkA-3ckkA:39.0","3ckkA-3ckkA:100.00"],["3DXY_A_SAMA1_0","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",6,"GLY A  54;GLY A  56;GLU A  77;ALA A 111;PHE A 131;ASP A 133","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-2.7A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);GOL A 302 ( 3.6A)","0.60A","3dxyA-3ckkA:19.9","3dxyA-3ckkA:24.49"],["3MTE_B_SAMB220_0","16S RRNA METHYLASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"GLY A  54;GLY A  56;ALA A 111;LEU A 130;PHE A 131","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-4.8A)","0.77A","3mteB-3ckkA:13.6","3mteB-3ckkA:23.08"],["3P2K_A_SAMA6735_0","16S RRNA METHYLASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"GLY A  54;GLY A  56;ALA A 111;LEU A 130;PHE A 131","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-4.8A)","0.69A","3p2kA-3ckkA:5.0","3p2kA-3ckkA:23.08"],["3P2K_C_SAMC6735_0","16S RRNA METHYLASE","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"GLY A  54;GLY A  56;ALA A 111;LEU A 130;PHE A 131","GOL A 302 ( 3.3A);SAM A 301 (-3.5A);SAM A 301 (-3.7A);SAM A 301 (-4.8A);SAM A 301 (-4.8A)","0.72A","3p2kC-3ckkA:14.1","3p2kC-3ckkA:23.08"],["4KOU_A_C04A207_1","UNCHARACTERIZED PROTEIN","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",3,"GLY A  56;GLU A 209;THR A 208","SAM A 301 (-3.5A);None;SAM A 301 (-2.8A)","0.57A","4kouA-3ckkA:undetectable","4kouA-3ckkA:19.58"],["4UCI_A_SAMA2409_0","RNA-DIRECTED RNA POLYMERASE L","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"THR A 208;GLY A  54;GLY A  56;GLY A  58;ALA A 111","SAM A 301 (-2.8A);GOL A 302 ( 3.3A);SAM A 301 (-3.5A);None;SAM A 301 (-3.7A)","0.95A","4uciA-3ckkA:5.4","4uciA-3ckkA:18.29"],["4UCI_B_SAMB2409_0","RNA-DIRECTED RNA POLYMERASE L","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"THR A 208;GLY A  54;GLY A  56;GLY A  58;ALA A 111","SAM A 301 (-2.8A);GOL A 302 ( 3.3A);SAM A 301 (-3.5A);None;SAM A 301 (-3.7A)","0.94A","4uciB-3ckkA:5.4","4uciB-3ckkA:18.29"],["4UCK_A_SAMA2409_0","RNA-DIRECTED RNA POLYMERASE L","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"THR A 208;GLY A  54;GLY A  56;GLY A  58;ALA A 111","SAM A 301 (-2.8A);GOL A 302 ( 3.3A);SAM A 301 (-3.5A);None;SAM A 301 (-3.7A)","0.93A","4uckA-3ckkA:5.4","4uckA-3ckkA:18.29"],["5C0O_F_SAMF301_0","TRNA (ADENINE(58)-N(1))-METHYLTRANSFERASE TRMI","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",5,"GLY A  56;GLY A  58;GLY A  59;LEU A  60;GLU A  77","SAM A 301 (-3.5A);None;None;None;SAM A 301 (-2.7A)","0.89A","5c0oF-3ckkA:11.2","5c0oF-3ckkA:undetectable"],["5YBB_A_SAMA601_1","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",4,"THR A 208;ASP A  52;GLU A  77;ASN A 110","SAM A 301 (-2.8A);SAM A 301 ( 4.9A);SAM A 301 (-2.7A);SAM A 301 (-3.5A)","1.06A","5ybbA-3ckkA:4.9","5ybbA-3ckkA:19.34"],["5YBB_B_SAMB601_1","TYPE I RESTRICTION-MODIFICATION SYSTEM METHYLTRANSFERASE SUBUNIT","3ckk","TRNA (GUANINE-N(7)-)-METHYLTRANSFERASE","Homo sapiens",4,"GLY A  56;GLY A  58;GLU A  77;ASN A 110","SAM A 301 (-3.5A);None;SAM A 301 (-2.7A);SAM A 301 (-3.5A)","0.47A","5ybbB-3ckkA:5.9","5ybbB-3ckkA:19.34"]]